ACO Name and Location

Lancaster General Health Community Care Collaborative, LLC
555 North Duke Street
PO Box 3555
Lancaster, PA 17604-3555

ACO Primary Contact

Primary Contact Name Kevin Bogari
Primary Contact Phone Number 717-544-5511
Primary Contact Email Address info@lghealth.org
 

Organizational Information 

ACO Participants

ACO Participants ACO Participant
in Joint Venture
John J. Eichenlaub, MD, P.C. (Drs. Eichenlaub and May) N
Quarryville Family Foot Care, P.C. N
Lancaster Rehabilitation Hospital, LLP Y
Lancaster General Health - Columbia Center (Twin Rose Family Medicine) N
Lancaster General Hospital N
Susquehanna Valley Women's Health Care, PC (May-Grant) N
Lancaster Pediatric Associates, LTD N
Lancaster Emergency Associates, LTD N
Lancaster Radiology Associates, LTD N
Orthopedic Associates of Lancaster, LTD N
Campus Eye Center, LTD N
Allergy and Asthma Center, P.C. N
Riverside Anesthesia Associates, LTD N
Hospice & Community Care N
Nephrology Associates of Lancaster, LTD (Hypertension and Kidney Specialists) N
Martin Podiatry, P.C.
N
Pulmonary Associates of Lancaster, LTD
N
Henderson Podiatry, LLC
N
Lancaster General Medical Group
N
Regional Gastroenterology Associates of Lancaster, LTD
N
Lancaster Skin Center, PC N
Lancaster Orthopedic Group, PC
N
EMG Group Ltd. LLC
N
Otolaryngology Physicians of Lancaster, LTD
N
Lancaster Otolaryngology
N
Family Eye Group, P.C.
N
Lancaster PET Partnership, LLP
Y
Palliative Medicine Consultants
N
Foot & Ankle Associates of Lancaster, LLC
N
The Heart Group of Lancaster General Health
N
MRI Group, LLP
Y
Westphal Associates, LTD
N
RGAL Anesthesia Services, LLC
N
Lancaster Ear Nose And Throat, LLC
N
Westphal Orthopedics, LLC
N
Lancaster Retina Specialists, P.C.
N
Francis J. Manning, MD, P.C.
N
Prime Anesthesia Associates, P.C.
N
Anesthesia Associates of Lancaster, LTD N
Conestoga Eye, PC N
Lancaster Urology, PC (Keystone Urology Specialists) N

ACO Governing Body

Last
Name
First
Name
Title/
Position
Member's
Voting Power -
Expressed
as a Percentage
or Number
Membership
Type
ACO Participant
Legal Business
Name/DBA,
if Applicable
Foley, MD T. Raymond Chairperson 1

ACO
Participant
Representative

Lancaster
General
Medical Group
Bogari, RN Kevin President 1 ACO
Participant
Representative
Lancaster
General
Hospital
Wood, MD John Medical
Director
1 ACO
Participant
Representative
Lancaster
General
Medical Group
Addis, MD Christopher Voting
Member
1 ACO
Participant
Representative
Lancaster
General
Hospital
Shepherd, MD Rebecca Voting
Member
1 ACO
Participant
Representative
Lancaster
General
Medical Group
Kraybill, MD Leon Voting
Member
1 ACO
Participant
Representative
Lancaster
General
Hospital
Young, MD Brian Voting
Member
1 ACO
Participant
Representative
Lancaster General
Health -
Columbia Center
(Twin Rose
Family Medicine)
Pulliam, MD Ward Voting
Member
1 ACO
Participant
Representative
The Heart
Group of
LG Health
Tifft, MD Stephen Voting
Member
1 ACO
Participant
Representative
Lancaster
General
Medical Group
Limpert Bruce Voting
Member
1 Medicare
Beneficiary
N/A
Legenstein Walt Voting
Member
1 Community
Representative
N/A
Polin, MD David Voting
Member
1 ACO
Participant
Representative
EMG Group
Pawlson, MD Brent Voting
Member
1 ACO
Participant
Representative
Lancaster
Pediatric
Associates
Pavlica, MD Michael Voting
Member
1 ACO
Participant
Representative
Family Eye
Group
Derrico, MD Ann Marie Voting
Member
1 FQHC Representative Union Community
Care
Briguglio, MD John Voting
Member
1 ACO
Participant
Representative
Lancaster
Radiology
Associates
Troxell, DO Corey Voting
Member
1 ACO
Participant
Representative
Lancaster
Orthopedic
Group
Magill, MD Thais Voting
Member
1 ACO
Participant
Representative
Palliative
Medicine
Consultants
Horvat, MD Craig Voting
Member
1 ACO
Participant
Representative
Pulmonary
Associates
of Lancaster
Harberson, MD Justin Voting
Member
1 ACO
Participant
Representative
Regional
Gastroenterology
Associates of
Lancaster. Ltd./RGi

Key ACO Clinical and Administrative Leadership

Kevin Bogari ACO Executive
John Wood, MD Medical Director
Elizabeth Katz Compliance Officer
Michael Ripchinski, MD Quality Assurance/Improvement Officer

Associated Committees and Committee Leadership

Committee Name Committee Leader Name and Position
Quality Committee Jeffrey Martin, MD - Chair
Finance Committee Stephen Tifft, MD - Chair
Clinical Integration Committee David Polin, MD - Chair

Types of ACO Participants, or Combinations of Participants, that Formed the ACO

  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
    • Performance Year 2020, $2,856,740
  • Second Agreement Period
    • Performance Year 2019, $0
    • Performance Year 2018, $0
    • Performance Year 2017, $0
  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 15%
      • Proportion of distribution to ACO participants: 70%
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2018
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

2020 Quality Performance Results 

ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI) #91) 0.63 0.95
ACO-13 Falls: Screening for Future Fall Risk 75.97 84.97
ACO-14 Preventive Care and Screening: Influenza Immunization 84.30 76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 88.89 81.67
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 81.52 71.46
ACO-19 Colorectal Cancer Screening 85.71 72.59
ACO-20 Breast Cancer Screening 84.42 74.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 77.26 83.37
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 8.59 14.70
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 70.95 72.87

* Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For previous years' Financial and Quality Performance Results, please visit Data.CMS.gov

Fraud and Abuse Waivers

ACO Participation Waiver:

The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

  • Parties to the arrangement: ACO Participants
  • Date of arrangement: 01/01/2017
  • Items, services, goods, or facility provided: Blood pressure cuffs, scales and pulse oximeters for patients with uncontrolled hypertension and congestive heart failure and blood pressure cuffs and a text-based remote monitoring solution for postpartum women at risk for worsening hypertension
  • Date and nature of any amendments to the arrangement, if applicable: 07/12/2019 amended to include downside risk.
Share This Page: